Stock Events

Stock Events

Denali Therapeutics (4DN.F) Q4 2024 Earnings

6NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.79

-0.71

-0.63

-0.55

Details

Expected EPS

-0.54610624926

Actual EPS

-0.5781699

Surprise EPS

-0.03

Surprise Percent

+5.87%

Description

Denali Therapeutics (4DN.F) has reported earnings of -0.5781699 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.